Inhibition of the renin-angiotensin system (RAS) has been shown to decrease mortality and morbidity in patients with heart failure and postmyocardial infarction. Experimental and clinical data ...

A new meta-analysis of randomized controlled trials of inhibitors of the renin ... trials suggest that activation of the renin–angiotensin system (RAS) may play a critical part in the genesis ...

The class of drugs, known as renin-angiotensin system (RAS) inhibitors, block the effects of the renin enzyme, relaxing blood vessels and allowing blood to flow more easily. They are widely used ...

A new study by researchers at the University of Virginia (UVA) School of Medicine has uncovered how prolonged use of renin-angiotensin system (RAS) inhibitors – commonly prescribed for high blood ...

Commonly prescribed drugs used to treat high blood pressure have been shown to, over time, wreck the kidneys' ability to ...

New research reveals a potential downside of long-term high blood pressure medication known as renin–angiotensin system (RAS) inhibitors. The study suggests that renin–angiotensin system (RAS ...

Now that they know the cause, researchers say the next step is to figure out how to use the effective blood pressure drugs known as renin-angiotensin system inhibitors – often called RAS inhibitors – ...

ONTARGET showed that dual renin–angiotensin system blockade prevents microalbuminuria ... it was a treatment-related adverse effect facilitated by RAS inhibition, particularly when ACE ...

versus placebo in adult IgAN patients on a stable dose of maximally-tolerated renin-angiotensin system (RAS) inhibitor ...

The class of drugs, known as renin–angiotensin system (RAS) inhibitors, block the effects of the renin enzyme, relaxing blood vessels and allowing blood to flow more easily. They are widely used ...

Because of the pivotal role of angiotensin II in the different steps of the cardiovascular continuum, more complete inhibition of the RAS to reduce the overall cardiovascular risk of an individual ...